Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer

ClinicalTrials.gov ID: NCT07402473

Public ClinicalTrials.gov record NCT07402473. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 4, 2026, 11:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

EUREKA Study: Phase 2 Study to Optimize Neoadjuvant Therapy in HER2-positive Early-stage Breast Cancer Using ctDNA and HARPS Biomarker Assay

Study identification

NCT ID
NCT07402473
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Rutgers, The State University of New Jersey
Other
Enrollment
50 participants

Conditions and interventions

Interventions

  • Carboplatin Drug
  • Docetaxel Drug
  • Pertuzumab Drug
  • Trastuzumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 25, 2026
Primary completion
Dec 30, 2027
Completion
Jun 29, 2028
Last update posted
Apr 22, 2026

2026 – 2028

United States locations

U.S. sites
7
U.S. states
1
U.S. cities
7
Facility City State ZIP Site status
RWJBarnabas Health - Trinitas Hospital and Comprehensive Cancer Center Elizabeth New Jersey 07202 Recruiting
RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton Hamilton New Jersey 08690 Recruiting
RWJBarnabas Health - Monmouth Medical Center Long Branch New Jersey 07740 Recruiting
Rutgers Cancer Institute New Brunswick New Jersey 08901 Recruiting
RWJBarnabas Health - Newark Beth Israel Medical Center Newark New Jersey 07112 Recruiting
RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset Somerville New Jersey 08876 Recruiting
RWJBarnabas Health - Community Medical Center Toms River New Jersey 08755 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07402473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2026 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07402473 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →